Overview
Product name | Recombinant SARS-COV-2 Spike S1 (N501Y, K417N, E484K) Protein |
---|
Catalog No. | RP02322 |
---|
Description | Recombinant SARS-COV-2 Spike S1 (N501Y, K417N, E484K ) Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Val16-Arg685(N501Y, K417N, E484K)) of SARS-COV-2 Spike S1(N501Y, K417N, E484K ) fused with His tag at the C-terminal. |
---|
Purity | > 95% by Tris-Bis PAGE;> 95% by SEC-HPLC |
---|
Endotoxin | < 1 EU/μg of the protein by LAL method. |
---|
Formulation | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4. |
---|
Species | SARS-COV-2 |
---|
Calculated MW | 75.9 kDa |
---|
Product information
Synonym | S1 protein; Spike glycoprotein Subunit1; S glycoprotein Subunit1; Spike protein S1 |
---|
Expression Host | HEK293 cells |
---|
Tag | C-His |
---|
Swiss-Prot | |
---|
Gene ID | |
---|
Usage guide
Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|
Reconstitution | Centrifuge the tube before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
---|
* For research use only. Not for therapeutic or diagnostic purposes.